Biotechnol Bioeng 2002,78(2):164–171.CrossRefPubMed JAK cancer 20. Simões M, Pereira MO, Sillankorva S, Azeredo J, Vieira MJ: The Effect of Hydrodynamic Conditions on the Phenotype of Pseudomonas fluorescens Biofilms. Biofouling 2007,23(4):249–258.CrossRefPubMed 21. Simos M, Simos LC, Vieira MJ: Physiology and Behavior of Pseudomonas fluorescens Single and Dual Strain Biofilms under Diverse Hydrodynamics Stresses. Int J Food Microbiol 2008,128(2):309–316.CrossRef 22. Stoodley P, Lewandowski Z, Boyle JD, Lappin-Scott HM: The

Formation of Migratory Ripples in a Mixed Species Bacterial Biofilm Growing in Turbulent Flow. Environ Microbiol 1999,1(5):447–455.CrossRefPubMed 23. Sillankorva S, Neubauer P, Azeredo J:Pseudomonas fluorescens Biofilms Subjected to Phage phiIBB-PF7A. BMC Biotechnol 2008, 8:79.CrossRefPubMed 24. Bloemberg GV, Wijfjes AHM, Lamers GEM, Stuurman N, Lugtenberg BJJ: Simultaneous Imaging of Pseudomonas fluorescens WCS365 Populations Expressing three Different Autofluorescent high throughput screening Proteins in the Rhizosphere: New Perspectives for Studying Microbial Communities. Mol Plant-Microbe Interact 2000,13(11):1170–1176.CrossRefPubMed 25. Bloemberg GV: Microscopic Analysis of Plant-bacterium Interactions using Autofluorescent Proteins. Eur J Plant Pathol 2007,119(3):301–309.CrossRef 26. Monier JM, Lindow SE: Spatial Organization of Dual-species Bacterial Aggregates on Leaf Surfaces. Appl Environ

Microbiol 2005,71(9):5484–5493.CrossRefPubMed 27. Schaudinn C, Stoodley P, Kainović A, O’Keeffe T, Costerton JW, Robinson DH, Baum MM, Ehrlich G, Webster PS: Bacterial Biofilms, Other Structures Seen as Mainstream Concepts. Microbe 2007,2(5):231–237. 28. Beech I, Hanjagsit L, Kalaji M, Neal AL, Zinkevich V: Chemical and Structural Characterization of Exopolymers Produced by Pseudomonas sp . NCIMB 2021 in Continuous Culture. Microbiology 1999,145(Pt 6):1491–1497.CrossRefPubMed 29. Marcotte L, Kegelaer G, Sandt C, Barbeau

J, Lafleur M: An Alternative Infrared Spectroscopy Assay for the Quantification of Polysaccharides in Bacterial Samples. Anal Biochem 2007,361(1):7–14.CrossRefPubMed 30. Serra D, Bosch A, Russo DM, Rodriguez ME, Zorreguieta A, Schmitt J, Naumann D, Yantorno O: Continuous Nondestructive Monitoring of Alanine-glyoxylate transaminase Bordetella pertussis Biofilms by Fourier Transform Infrared Spectroscopy and other Corroborative Techniques. Anal Bioanal Chem 2007,387(5):1759–1767.CrossRefPubMed 31. Filippov MP, Kohn R: Determination of Composition of Alginates by Infrared Spectroscopic Method. Chem Zvesti 1974,28(6):817–819. 32. Lawrence JR, Neu TR: Confocal Laser Scanning Microscopy for Analysis of Microbial Biofilms. Methods Enzymol 1999, 310:131–144.CrossRefPubMed 33. Chalmers NI, Palmer RJ, Du-Thumm L, Sullivan R, Shi WY, Kolenbrander PE: Use of Quantum Dot Luminescent Probes to Achieve Single-cell Resolution of Human Oral Bacteria in Biofilms. Appl Environ Microbiol 2007,73(2):630–636.CrossRefPubMed 34.

Furthermore, strains containing both the arsenite oxidase and any type of transporter gene showed a higher CP-673451 mw arsenite resistance level. These results

suggest that bacteria capable of both arsenite oxidation and arsenite efflux mechanisms have an elevated arsenite resistance level. We also found that arsenite can be fully oxidized even at concentrations close to the MIC in arsenite oxidizers SY8 and TS44 (data not shown). Recently, we have amplified and sequenced the arsC/ACR3 operon (arsC 1-arsR-arsC 2-ACR3-arsH) in the adjacent downstream region of aoxB in Pseudomonas. sp. TS44 (data not shown; GenBank, EU311944). Kashyap et al. [31] found that in Agrobacterium tumefaciens strain 5A, disruption of aoxR caused a loss in the ability to oxidize arsenite and furthermore resulted in an apparent reducing phenotype probably due to the action of cytosolic ArsC and subsequent pumping out of As(III). It is noteworthy to point out that there are two processes of As(V)

reduction in the environment. One is the JQ1 manufacturer use of As(V) as a terminal electron acceptor under anaerobic conditions. The other is the intracellular reduction of As(V) to As(III) under aerobic conditions due to the ArsC-dependent cytoplasmic arsenate reduction as part of the arsenic resistance system (ars operon). Since As(III) is the species being pumped out of cell (by arsB or ACR3), the presence of HSP90 As(III) in the environments can also be detected under aerobic condition. One of the main purposes in this research was

to determine the correlation among the bacterial arsenite resistance level, bacterial distribution in the environment and the different types of arsenite transporter gene families. We found that the ACR3 genotypes were predominant over arsB (33 ACR3 vs. 18 arsB) in our samples which was in agreement with a report by Achour et al. [16]. In addition, we found any two types of arsenite transporter genes can coexist in the same strain [arsB and ACR3(1), arsB and ACR3(2), ACR3(1) and ACR3(2)]. Related reports also found the presence of multiple sets of arsenic resistance genes and operons in one strain, especially the arsenite transporter genes. Pseudomonas putida KT2440 contains two operon clusters (arsRBCH) for arsenic resistance [38]. Acidithiobacillus caldus has three sets of arsenic resistance determinants, one located on the chromosome and the other two exist on the transposon [39, 40]. Corynebacterium glutamicum has two typical arsenic-resistant operons and additional arsB and arsC genes, of which two arsenite transporter genes belonged to the ACR3(1) group [41]. The genome of Herminiimonas arsenicoxydans revealed the presence of four arsenic resistance operons including two arsB genes and one ACR3 [42]. Multiple sets of arsenic resistance determinants were also reported in B. subtilis [18] and Desulfovibrio desulfuricans G20 [43].

8% agarose gel and transferred without prior denaturation to a nylon membrane (Nytran SuPerCharge) by vacuum blotting in 10X SSC buffer (Vacuum Blotter; MP Biomedicals). The air-dried membrane was then UV cross-linked before hybridization with the pMyBK1 [digoxigenin]dUTP-labelled probe using standard stringency conditions. Hybridization signals were detected with anti-digoxigenin-alkaline phosphatase conjugate and CDP-Star as the substrate, according to the manufacturer’s MK0683 cell line instructions (Roche Applied Science). The pMyBK1 probe was generated by PCR amplification with primer pair pMyBK1-F1/R2 (Additional file 1: Table S1). For protein immunobloting, 107–108 c.f.u. from M. yeatsii and M. capricolum

subsp. capricolum (Mcc) late-exponential-phase cultures were spotted under vacuum onto a nitrocellulose membrane. Immunoblotting was carried Ku-0059436 chemical structure out as described previously [41] except that the binding of spiralin-antibodies was visualized by using a goat anti-rabbit immunoglobulin G–peroxidase conjugate and the Super Signal West Pico chemoluminescent substrate (Pierce). Plasmid constructs and transformation experiments Several derivatives of pMyBK1 (pCM-H, pCM-P, pCM-C, pCM-K1-5) were constructed by inserting BglII-digested amplification products from pMyBK1 (BglII site in the primer sequences) into BglII-linearized pSRT2 [42]. Primers used

for amplification of fragments from pMyBK1 are listed in Additional file 1: Table S1. In each construct (see Results section and Figure 2), the CDSs of pMyBK1 Casein kinase 1 were kept in the same orientation as that of the pSRT2 tetM gene. To produce pCM-K3-spi, the spiralin gene and its promoter were amplified from S. citri GII3 genomic DNA with primer pair SpiERI-F/R, prior to restriction with EcoRI and ligation into EcoRI-linearized pCM-K3. In pCM-K1ΔB, the CDSB of pCM-K1 was disrupted by a 4-bp insertion creating

a unique XhoI site. To introduce the 4-bp frameshift mutation, the amplification product of pCM-K1 using DeltacdsB-F/DeltacdsB-R primers was restricted by XhoI before circularization by self-ligation. Figure 2 Structural organization and replication ability of pMyBK1 and derivatives. A. Plasmid constructs are described in Methods. Putative promoter and terminator of CDSA and CDSB are indicated for pMyBK1 only. Direct repeats (□) , inverted repeats (▸◂) and the GC-rich region (|||||) are indicated only for the pCM-C derivative. B, BglII; E, EcoRI; spi, Spiroplasma citri spiralin gene; tetM, tetracycline resistance gene from transposon Tn916, pBS, plasmid pBluescript. The signs on the right indicate the ability (+) and inability (−) to replicate in Mycoplasma yeatsii type strain GIH TS. * indicates a frameshift mutation in the cdsB sequence of pCM-K1ΔB. B. The replication ability of 4 pMyBK1 derivatives was evaluated in mollicute species belonging to the Spiroplasma phylogenetic group and shown to be initially plasmid-free: M. yeatsii #13156, M. putrefaciens KS1 TS, M.

Bioinformatic analysis Several high-throughput applications have been developed recently to design diagnostic primers using the whole genome sequence information including KPATH, Insignia, TOFI, and TOPSI [34–40]. Among them, KPATH, Insignia, and TOPSI have the potential to be used selleck products for design of real-time PCR primers for qRT-PCR

based assays for Las, whereas TOFI is used to design signatures for microarray-based assays. These methods mentioned above can be basically categorized into alignment-free and alignment-based approaches. The alignment-free approach uses both coding and non-coding regions of the genome and is useful for the genomes with less accurate sequence information, but generally result in high false positive rates as it does not involve pre-screening of the selected genomic loci for their discriminatory ability [37]. The alignment-based approach involves pre-screening of the selected

genomic loci for their discriminatory ability [34]. This approach does not consider the genome annotation of genic and non-genic information, but rather aligns bigger regions of the genome, hence prone to lose shorter discriminatory sequence regions. Additionally, discriminatory ability of the selected regions are screened bioinformatically only on limited number of closely related species, which provide more AP24534 cell line opportunities for false positives. We therefore took a complementary bioinformatics approach by pre-screening shorter genic regions against the nucleotide sequence database (nt) at NCBI, to identify all the possible

unique genic regions from the Las genome. The natural selection acts more strongly on genic region, hence use of discriminatory sequences in this region results in less false positives as the organisms are under selection pressure [41]. Additionally, pre-screening against the nt is more effective as it contains the largest pool of well-annotated nucleotide sequences from different organisms. Thymidine kinase We envisioned that these two steps would result in more specific detection of target organism with less false positives, hence are included in our bioinformatics approach. There are ~1100 genes assigned to the Las genome. Therefore, manual searching of each of these sequences against the nt database using BLAST program [42, 43] is a laborious and time consuming procedure. Hence, we automated this sequence similarity search step by developing a standalone PERL script (Additional file 1). This script performed the similarity searches for each of the Las gene against the specified database with hard-coded parameters for the BLAST program. Further, manual analysis of the resulting BLAST search output files is also laborious and time consuming; we therefore, automated this step by developing a second PERL script (Additional file 2).

It was taught that click here NK cells belong to the innate immune system; however, this has recently been challenged as ‘adaptive’ memory-like NK cells have been reported [18, 19]. NK cells express some chemokine receptors such as CCR2, CCR5, CXCR3 and CX3CR1. Thus, they can respond to a variety of chemokines and migrate to distinct inflammatory sites. The trafficking patterns of NK cells are poorly understood; however, it appears that chemokines produced by different cells in a specific organ may direct NK cell migration to the target organ [20]. For instance, the CX3CL1 produced by neurons is necessary

and sufficient to conduct CX3CR1-bearing NK cells to inflamed brain [21]. This suggests that organ-intrinsic elements may be important in shaping NK cell homing and might be an appropriate target for approaching to treating the inflammatory CNS disorders. NK cell function is modulated by several activating and inhibitory receptors. NK cell receptors can be divided into functionally or structurally defined groups. In

mammals, there are two main classes of NK cell receptors, the immunoglobulin (Ig) superfamily receptors that include the killer cell Ig-like receptors (KIR), natural cytotoxicity receptors (NCR) NKp30, NKp44 and NKp46, and the structurally unrelated killer cell lectin-like receptors (KLR) that include the NKR-P1, CD94/NKG2 and NKG2D receptor families. NK Selleckchem Roxadustat cell receptors can also functionally divided into various groups based on their ligands (Table 1). Majority of these receptors are encoded in the NK gene complex (NKC) and leucocyte receptor cluster (LCR) [13]. Several NK cell receptors are also expressed on other cells such as T cells [13, 15, 17]. The major characteristics of NK cell receptors are described in the Table 1. NK cells ZD1839 have the potent inflammatory and destructive effects and are potentially dangerous. It is not clear how NK cells achieve tolerance. The engagement of self MHC-I molecules by inhibitory

NK cell receptors may be the principle mechanism by which killing of normal cells is prevented. The virally infected cells and tumour cells often downregulate MHC-I expression to evade CD8+ T cell recognition, but this makes them sensitive to NK cell-mediated killing. Several distinct models have been proposed, and the ‘missing self’ was the first hypothesis that suggested NK cells monitor cells for normal MHC-I expression by inhibitory NK cell receptors [22]. However, the NK cell tolerance mechanism is more complex as a subset of mouse NK cells lacking inhibitory MHC-I receptors have been shown to be functional or high-level expression of activating ligands may lead to NK cell activation even in the presence of inhibitory ligands [23].

01 EU/μg pDNA by the Triton X-114 extraction. For polyI:C and imiquimod, polymyxin B, which binds to LPS, was added to cells at a final concentration of 5 μg/mL. ODNs, nucleotides and nucleosides were used as obtained without further purification or addition of polymyxin B. TLR9 KO mice were purchased from the Oriental Yeast Company (Tokyo, Japan). C57BL/6 WT mice selleck screening library and Institute for Cancer Research (ICR)

mice were purchased from Japan SLC (Shizuoka, Japan) and maintained on a standard food and water diet under conventional housing conditions. All animal experiments were conducted in accordance with the principles and procedures outlined in the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The protocols for animal experiments were approved by the Institutional Animal Experimentation Committee of the Graduate School of Pharmaceutical Sciences, Kyoto University. In the experiment of subcutaneous injection

of ODN into mouse footpad, 3 nmol of ODN1668 in 20 μL PBS were subcutaneously injected into the footpad of the right hind leg of male ICR mice with or without 10 nmol DNase I-treated or untreated ODN1720. Before and 24 h after injection of ODN, the thickness of footpad was measured using a micrometer caliper with a minimum scale of 10 μm (Mitutoyo, Kawasaki, Japan). Separately, the footpad was removed at 24 h after injection and submerged into

4% paraformaldehyde in PBS for 24 h at 4°C. The fixed footpad tissues selleck chemicals were decalcified and embedded in paraffin and sectioned into 3-μm slices. The paraffin sections were stained with hematoxylin and eosin to evaluate the infiltration of blood cells. The number of mononuclear cells and neutrophils infiltrating into the injection site in 25 mm2 was counted. Splenic macrophages were collected as previously described 16 and cultured on 96-well culture plates at a density of 3×105 cells/well in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS), penicillin G (100 U/mL), streptomycin (100 μg/mL), L-glutamine (292 μg/mL) and 2-mercaptoethanol (10−5 M). They were used for the cytokine release experiment soon after isolation. The murine macrophage-like cell line, RAW264.7 cells, was cultured much on 96-well culture plates at a density of 5×104 cells/well in RPMI-1640 supplemented with 10% FBS, penicillin G (100 U/mL), streptomycin (100 μg/mL) and L-glutamine (292 μg/mL). They were cultured for 24 h prior to use. The human leukemic plasmacytoid DC line, PMDC05 cells 17, was cultured on 96-well culture plates at a density of 4×105 cells/well in Iscove’s Modified Dulbecco’s Medium supplemented with 10% FBS, penicillin G (100 U/mL), streptomycin (100 μg/mL) and L-glutamine (292 μg/mL). They were plated before the cytokine release experiment. RAW264.

There was a relation between fungal exposure at home and the spontaneous PBMC secretion of IL-6, IL-10 and IL-12 among subjects with sarcoidosis. A significant relationship was observed between disease severity, measured as chest X-ray scores indicating granuloma infiltration, and the P-glucan- and LPS-induced secretion of all cytokines. There was also a positive relation between the P-glucan-induced secretion of IL-12 and the duration of symptoms. There are some limitations to the study. The FCWA BGJ398 in vitro and LPS preparations used in the study were chemically well-defined compounds of bacterial and fungal origins but these are not wholly representative of the agents as present in the environment [15]. S-glucan and P-glucan

were purified from Alcaligenes faecalis, but in nature β-glucan is present together with capsular materials and chitin. The chitin preparation used was a de-acetylated form of chitin. LPS is a chemically purified lipopolysaccharide from Gram-negative bacteria, whereas the endotoxin present in nature also comprises proteins and sugars from the cell wall of Gram-negative bacteria [22].

In view of these differences between the substances used in the PBMC stimulation experiments and natural agents, caution should be applied in the interpretation of the in vitro findings and their relevance for clinical conditions. If, on the other hand, observations from exposures and cytokines in vivo parallel the in vitro results, the validity of the latter is supported. The in vitro method used also has some limits in terms of interpretation. A potential shortcoming Small Molecule Compound Library is the lack of definition of different cell types. Due to the chronic inflammation subjects with sarcoidosis might have a different cell population particularly regarding lymphocytes, both in numbers and subtypes. Thus differences in cytokine production between patients with sarcoidosis and controls could be due to different proportions of responsive cells in the PBMC isolates. PBMC consist, however, mainly of monocytes and lymphocytes and the proportion reflects the monocyte/lymphocyte proportion

in white blood cells. These were counted in all our sarcoidosis Selleck Alectinib patients and only minor changes were present in the mono/lymph ratio compared to controls. From a clinical viewpoint, the presence of an inflammation is the most important issue for the patient. Whether or not this is due to a different distribution of cells is interesting from a mechanistic point of view, but not for the patient. The conclusion that subjects with sarcoidosis react more to FCWA and to the fungal exposure at home is thus a relevant finding, irrespective of the underlying mechanism. The results confirm findings from many previous investigations where FCWA were found to have important immunomodulating characteristics [14]. The FCWA used here had different effects on the secretion of cytokines from PBMC. P-glucan induced a high secretion of all cytokines.

Interactions with warfarin [decrease of international normalized ratio (INR)] need to be controlled with frequent INR monitoring. There are no data with regard to marcumar, which is used more commonly in European countries. Adjunctive teriflunomide treatment with IFN-beta or Rapamycin glatirameracetate has been evaluated in several trials – Phase II trials showed a favourable safety profile

and positive MRI outcomes [119] (and ClinicalTrials.gov NCT00475865), the results of extensions and other studies are pending. Regarding long drug half-life, drug washout after discontinuation can be accelerated via cholestyramine or activated charcoal powder [117], which is relevant in cases of unplanned pregnancy, newly acquired co-morbidities or rapid switch to other immune medications. Long-term safety data on teriflunomide are being followed-up in extensions of Phases II and III trials (ClinicalTrials.gov NCT00228163, NCT00803049) MK 2206 [120]. Experience on SADRs has been widely favourable, but includes the rare occurrence of potentially fatal infections and tuberculosis (Table 1). Whereas severe liver injury was not reported in the clinical development programme of teriflunomide, few cases were reported with leflunomide. Thus, risk assessment for teriflunomide is conservative, with extrapolation from post-marketing experience with leflunomide of more than 2·1 million patient years. Plasma levels of teriflunomide can

be measured that might be useful in special situations such as pregnancy in order to monitor the CYTH4 rapid elimination

procedure [117]. Ongoing or projected studies are investigating the influence of teriflunomide on brain pathology by use of MRI (ClinicalTrials.gov NCT01881191) and the role of lymphocyte subsets as biomarkers for teriflunomide therapy (ClinicalTrials.gov NCT01863888). Dimethylfumarate (DMF) is described to have differential modes of action, including anti-inflammatory [e.g. enhanced T helper type 2 (Th2) response, T cell apoptosis] and potentially neuroprotective aspects [modulation of the nuclear (erythroid-derived 2)-related factor (Nrf2) pathway, anti-oxidative effects] [121, 122]. Two Phase III trials have shown efficacy of DMF in RRMS [123, 124]. Due to possible gastrointestinal side effects, application of DMF in patients with severe gastrointestinal disorders such as peptic ulcers should be assessed cautiously. Whereas DMF (Tecfidera®) is approved in the United States, as of October 2013 marketing in the European Union has not yet begun. DMF is an oral compound administered twice daily at a dose of 240 mg. The administration of 720 mg per day has not shown higher efficacy than the 480 mg daily dose [123, 124]. In order to improve the tolerability of DMF, dose titration is recommended. Lymphopenia will presumably be addressed in safety monitoring schedules in European treatment guidelines. This has not been accounted for in US prescription guidelines.

com.au American association of kidney patients: http://www.aakp.org Life Options: http://lifeoptions.org/ Kidney Health Australia: http://www.kidney.org.au/ForPatients/Treatmentoptions/ConservativeCare/tabid/807/Default.aspx

Kidney Health New Zealand: http://www.kidneys.co.nz/resources/file/Conservative%20treatment.pdf Renal Resource Centre: http://www.renalresource.com/pdf/IntroCCACKD.pdf Helen Healy, Ilse Berquier and Susan M Crail Mr MF was a 72-year-old married father living independently with his wife. Mr MF was admitted electively for non-operative correction of a known left renal artery stenosis. Previous investigations reported two small kidneys with total obstruction of the right renal artery and >60% obstruction PI3K inhibitor of the left. Recent health was compromised by multiple admissions to coronary care (CCU) with chest pain and acute pulmonary oedema (APO) Ku-0059436 molecular weight despite recent plasty of a blocked coronary graft, placed in 2002. An interventional radiologist accessed the left renal artery. Unfortunately, the tip of the catheter guide wire snapped off in the proximal part of the vessel, totally

occluding it. An interventional cardiologist was unable to retrieve the remnant wire via a brachial approach. The entry site at the right brachial artery puncture developed a hematoma. The vascular surgeons opined that open revascularization of the blocked renal artery was not an option. Mr MF was anuric and the renal team were asked, for the first time, to consult. The patient was noted to have excellent insight into his medical problems and was keen to proceed with a trial of dialysis. During the first haemodialysis Acetophenone treatment, Mr MF lost consciousness for 15 s, requiring CPR. His peripheral circulation returned spontaneously but, after the event, the hematoma of the right arm was noted to be larger. The vascular surgeons repaired a

pseudoaneurysm in an emergency procedure. Mr MF remained olig/anuric and required ongoing dialysis. He continued to experience chest pain, difficulty breathing and ECG changes indicative of ischemia. During discharge planning it emerged that Mr MF had a complex social situation with a son who had a drug addiction, two children in foster care and one grandchild in the custody of Mr MF’s daughter who happened to live in the same unit complex as her parents. Mr MF was dialysis dependent and continued to experience chest pain due to demand ischemia at the time of his discharge. Mr MF was re-admitted less than a week later with chest pain and APO, necessitating emergent dialysis. He was depressed, dreaded the thought of further episodes of APO at home and had contemplated suicide. A Psychologist diagnosed a major depressive episode and recommended anti-depressant medication and psychotherapy. During the admission Mr MF was unable to dialyse without episodes of hypotension, precipitating early cessation of treatment.

LASV- and MOPV-infected MΦs induced a significant increase in the percentage of CD69-, NKp30-, NKp44- (only for LASV-infected MΦs) expressing NK cells (Fig. 2C and E). However, the expression of the NKp46 and NKG2D activating and inhibitory KIR2DL2/3 receptor by NK cells was not modified (data not shown). The percentage of NK cells expressing CXCR3 was significantly lower in the presence of LASV- and MOPV-infected MΦs, but analysis of the levels of CXCR3 mRNA revealed no difference between mock and infected cocultures (Fig. 2C, E, and

data not shown). The modification of the NK-cell repertoire depends on viral replication, as there is no change in the expression of most NK-cell surface molecules in response NVP-BEZ235 to inactivated viruses. Still, the infection of MΦs with inactivated LASV induced a significant decrease in NKp30-expressing NK cells and an increase in CXCR3-expressing NK cells. LPS-activated MΦs induced a significant increase in CD69 and NKp44 expression and a decrease in NKp30 and CXCR3 expression in NK cells. The stimulation of NK cells with IL-2/PHA in the presence of MΦs triggered a significant increase in the expression

of CD69 by NK cells, together with a decrease in the number of CXCR3-expressing NK cells. Unlike DCs, LASV-, and MOPV-infected MΦs induced a significant increase in NK-cell proliferation, as shown by the analysis of Ki67 expression (Fig. 2D and E) and BrdU incorporation (data not shown). IL-2/PHA stimulation induced a significant increase in the number of Ki67-expressing NK selleck cells in NK/DC cocultures. Our results clearly demonstrate that NK cells are strongly activated and proliferate in the presence of LASV- and MOPV-infected MΦs, but not in the presence of infected DCs. We used PMA/ionomycin and IL-12/IL-18 as positive controls of IFN-γ production by NK cells. The infection of DCs with LASV or MOPV did not induce IFN-γ gene expression, whereas a significant increase in IFN-γ Resminostat mRNA

levels was observed in cocultures of NK cells with LASV- or MOPV-infected MΦs and with LPS-activated APCs or by IL-2/PHA stimulation (Fig. 3A). Low levels of IFN-γ protein production were observed by flow cytometry (Fig. 3B), but IFN-γ was not detected in the supernatant of cocultures by ELISA or in ELISPOT assays (data not shown). We also observed an increase in levels of TNFα and β transcripts but TNF-α was not detected in NK cells by intracellular flow cytometry or ELISA (data not shown). Thus, our results demonstrate that, despite the increase in IFN-γ gene transcription, LASV- and MOPV-infected MΦs do not induce major IFN-γ secretion. NK cells mediate cytotoxicity either via the exocytosis of lytic granules containing perforin and granzymes or through death receptor ligands, such as FasL or TRAIL, transmitting apoptotic signals.